These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 24012486)

  • 1. Intact Doxil is taken up intracellularly and released doxorubicin sequesters in the lysosome: evaluated by in vitro/in vivo live cell imaging.
    Seynhaeve ALB; Dicheva BM; Hoving S; Koning GA; Ten Hagen TLM
    J Control Release; 2013 Nov; 172(1):330-340. PubMed ID: 24012486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Manganese-52: applications in cell radiolabelling and liposomal nanomedicine PET imaging using oxine (8-hydroxyquinoline) as an ionophore.
    Gawne P; Man F; Fonslet J; Radia R; Bordoloi J; Cleveland M; Jimenez-Royo P; Gabizon A; Blower PJ; Long N; de Rosales RTM
    Dalton Trans; 2018 Jul; 47(28):9283-9293. PubMed ID: 29796500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics, brain delivery, and efficacy in brain tumor-bearing mice of glutathione pegylated liposomal doxorubicin (2B3-101).
    Gaillard PJ; Appeldoorn CC; Dorland R; van Kregten J; Manca F; Vugts DJ; Windhorst B; van Dongen GA; de Vries HE; Maussang D; van Tellingen O
    PLoS One; 2014; 9(1):e82331. PubMed ID: 24416140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-CD30 antibody conjugated liposomal doxorubicin with significantly improved therapeutic efficacy against anaplastic large cell lymphoma.
    Molavi O; Xiong XB; Douglas D; Kneteman N; Nagata S; Pastan I; Chu Q; Lavasanifar A; Lai R
    Biomaterials; 2013 Nov; 34(34):8718-8725. PubMed ID: 23942212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liposomal Doxorubicin
    Redruello-Guerrero P; Córdoba-Peláez P; Láinez-Ramos-Bossini AJ; Rivera-Izquierdo M; Mesas C; Ortiz R; Prados J; Perazzoli G
    Curr Drug Deliv; 2024; 21(10):1346-1361. PubMed ID: 38099532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TXB-001, a newly-developed polymer-conjugated anthracycline: Significantly lower adverse effects in animal models of alopecia and hand-foot syndrome.
    Hirakata M; Tomikawa E; Sakai C; Uchida M; Okano T; Shimozono R; Kawai M; Itaba S; Munakata L; Suzuki R; Oshida K
    Toxicol Appl Pharmacol; 2024 Apr; 485():116912. PubMed ID: 38521368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A real-world analysis of FDA Adverse Event Reporting System (FAERS) events for liposomal and conventional doxorubicins.
    Su H; Jia J; Mao Y; Zhu R; Li Z
    Sci Rep; 2024 Mar; 14(1):5095. PubMed ID: 38429374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Encapsulated Checkpoint Blocker Before Chemotherapy: The Optimal Sequence of Anti-CTLA-4 and Doxil Combination Therapy.
    Alimohammadi R; Alibeigi R; Nikpoor AR; Chalbatani GM; Webster TJ; Jaafari MR; Jalali SA
    Int J Nanomedicine; 2020; 15():5279-5288. PubMed ID: 32801691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kupffer cells determine intrahepatic traffic of PEGylated liposomal doxorubicin.
    Jiang K; Tian K; Yu Y; Wu E; Yang M; Pan F; Qian J; Zhan C
    Nat Commun; 2024 Jul; 15(1):6136. PubMed ID: 39033145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Design-Conversed Strategy Establishes the Performance Safe Space for Doxorubicin Nanosimilars.
    Nagpal S; Png Yi Jie J; Malinovskaya J; Kovshova T; Jain P; Naik S; Khopade A; Bhowmick S; Shahi P; Chakra A; Bhokari A; Shah V; Gelperina S; Wacker MG
    ACS Nano; 2024 Feb; 18(8):6162-6175. PubMed ID: 38359902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding the In Vitro-In Vivo Nexus: Advanced correlation models predict clinical performance of liposomal doxorubicin.
    Gan K; Li Z; Darli PM; Wong T; Modh H; Gottier P; Halbherr S; Wacker MG
    Int J Pharm; 2024 Apr; 654():123942. PubMed ID: 38403086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The supramolecular processing of liposomal doxorubicin hinders its therapeutic efficacy in cells.
    Carretta A; Moscardini A; Signore G; Debellis D; Catalano F; Marotta R; Palmieri V; Tedeschi G; Scipioni L; Pozzi D; Caracciolo G; Beltram F; Cardarelli F
    Mol Ther Oncol; 2024 Sep; 32(3):200836. PubMed ID: 39050990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid conjugate dissociation analysis improves the in vivo understanding of lipid-based nanomedicine.
    van Os WL; Wielaert L; Alter C; Davidović D; Šachl R; Kock T; González UU; Arias-Alpizar G; Vigario FL; Knol RA; Kuster R; Romeijn S; Mora NL; Detampel P; Hof M; Huwyler J; Kros A
    J Control Release; 2024 Jul; 371():85-100. PubMed ID: 38782063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combinatorial synthesis and screening of cancer cell-specific nanomedicines targeted via phage fusion proteins.
    Gillespie JW; Gross AL; Puzyrev AT; Bedi D; Petrenko VA
    Front Microbiol; 2015; 6():628. PubMed ID: 26157433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Theranostic Attributes of Acoustic Cluster Therapy and Its Use for Enhancing the Effectiveness of Liposomal Doxorubicin Treatment of Human Triple Negative Breast Cancer in Mice.
    Bush N; Healey A; Shah A; Box G; Kirkin V; Eccles S; Sontum PC; Kotopoulis S; Kvåle S; van Wamel A; Davies CL; Bamber J
    Front Pharmacol; 2020; 11():75. PubMed ID: 32153400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification of Unencapsulated Drug in Target Tissues Demonstrates Pharmacological Properties and Therapeutic Effects of Liposomal Topotecan (FF-10850).
    Kimura T; Okada K; Morohashi Y; Kato Y; Mori M; Kato H; Matsumoto T; Shimoyama S
    Pharm Res; 2024 Apr; 41(4):795-806. PubMed ID: 38536615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carrier-Free, Amorphous Verteporfin Nanodrug for Enhanced Photodynamic Cancer Therapy and Brain Drug Delivery.
    Quinlan JA; Inglut CT; Srivastava P; Rahman I; Stabile J; Gaitan B; Arnau Del Valle C; Baumiller K; Gaur A; Chiou WA; Karim B; Connolly N; Robey RW; Woodworth GF; Gottesman MM; Huang HC
    Adv Sci (Weinh); 2024 May; 11(17):e2302872. PubMed ID: 38445882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In Vitro and Preclinical Antitumor Evaluation of Doxorubicin Liposomes Coated with a Cholesterol-Based Trimeric β-D-Glucopyranosyltriazole.
    Maciel E Silva AT; Maia ALC; Silva JO; Miranda SEM; Cantini TS; de Barros ALB; Soares DCF; de Magalhães MTQ; Alves RJ; Ramaldes GA
    Pharmaceutics; 2023 Dec; 15(12):. PubMed ID: 38140092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear localization signal-tagged systems: relevant nuclear import principles in the context of current therapeutic design.
    Goswami R; Gupta A; Bednova O; Coulombe G; Patel D; Rotello VM; Leyton JV
    Chem Soc Rev; 2024 Jan; 53(1):204-226. PubMed ID: 38031452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent Preclinical and Clinical Progress in Liposomal Doxorubicin.
    Aloss K; Hamar P
    Pharmaceutics; 2023 Mar; 15(3):. PubMed ID: 36986754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.